Henning Gruell

7.2k total citations · 1 hit paper
52 papers, 1.2k citations indexed

About

Henning Gruell is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Henning Gruell has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 20 papers in Virology and 14 papers in Immunology. Recurrent topics in Henning Gruell's work include SARS-CoV-2 and COVID-19 Research (21 papers), HIV Research and Treatment (20 papers) and Immune Cell Function and Interaction (11 papers). Henning Gruell is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (21 papers), HIV Research and Treatment (20 papers) and Immune Cell Function and Interaction (11 papers). Henning Gruell collaborates with scholars based in Germany, United States and Slovakia. Henning Gruell's co-authors include Florian Klein, Kanika Vanshylla, Philipp Schommers, Clara Lehmann, Florian Kurth, Pinkus Tober‐Lau, Leif Erik Sander, Christoph Kreer, David Hillus and Michel C. Nussenzweig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Henning Gruell

48 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

2022 243 citations Henning Gruell, Kanika Vanshylla et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henning Gruell Germany	17	782	377	317	234	185	52	1.2k
Wen Shi Lee Australia	15	807 1.0×	272 0.7×	459 1.4×	223 1.0×	164 0.9×	39	1.2k
Kshitij Wagh United States	16	568 0.7×	489 1.3×	281 0.9×	294 1.3×	173 0.9×	28	1.1k
Kristen W. Cohen United States	16	389 0.5×	550 1.5×	611 1.9×	310 1.3×	168 0.9×	28	1.2k
Haili Tang United States	12	452 0.6×	447 1.2×	271 0.9×	157 0.7×	100 0.5×	21	786
Halima Medjahed Canada	19	761 1.0×	601 1.6×	484 1.5×	159 0.7×	167 0.9×	55	1.3k
Valérie Lorin France	18	312 0.4×	323 0.9×	399 1.3×	171 0.7×	154 0.8×	26	886
Justin Pollara United States	20	386 0.5×	738 2.0×	773 2.4×	268 1.1×	300 1.6×	58	1.5k
Célia Pedroso Brazil	18	557 0.7×	157 0.4×	274 0.9×	202 0.9×	36 0.2×	41	1.2k
Gloria Agatic Switzerland	8	391 0.5×	171 0.5×	235 0.7×	156 0.7×	178 1.0×	10	864
Ramón Lorenzo-Redondo United States	14	621 0.8×	578 1.5×	184 0.6×	204 0.9×	23 0.1×	47	1.0k

Countries citing papers authored by Henning Gruell

Since Specialization

Citations

This map shows the geographic impact of Henning Gruell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Gruell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Gruell more than expected).

Fields of papers citing papers by Henning Gruell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henning Gruell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Gruell. The network helps show where Henning Gruell may publish in the future.

Co-authorship network of co-authors of Henning Gruell

This figure shows the co-authorship network connecting the top 25 collaborators of Henning Gruell. A scholar is included among the top collaborators of Henning Gruell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Gruell. Henning Gruell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mellinghoff, Sibylle C., Sandra Robrecht, Rosanne Sprute, et al.. (2024). Hybrid immunity to SARS‐CoV ‐2 in patients with chronic lymphocytic leukemia. European Journal Of Haematology. 112(5). 788–793.

Mendizábal, Nieves Vélez de, Stephan Becker, Gerd Fätkenheuer, et al.. (2024). Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administration. Journal of Pharmacokinetics and Pharmacodynamics. 52(1). 3–3.

Gruell, Henning, et al.. (2024). Therapeutic interfering particles against HIV: molecular parasites reducing viremia. Signal Transduction and Targeted Therapy. 9(1). 287–287. 1 indexed citations

Weber, Timm, S. Rose, Kanika Vanshylla, et al.. (2023). Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool. Science Immunology. 8(89). eadk5845–eadk5845. 15 indexed citations

Korenkov, Michael, Matthias Zehner, Hadas Cohen‐Dvashi, et al.. (2023). Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants. Immunity. 56(12). 2803–2815.e6. 16 indexed citations

Augustin, Max, Melanie Stecher, Veronica Di Cristanziano, et al.. (2023). 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study. Frontiers in Immunology. 14. 1226622–1226622. 3 indexed citations

Barnes, Christopher O., Till Schoofs, Priyanthi N.P. Gnanapragasam, et al.. (2022). A naturally arising broad and potent CD4-binding site antibody with low somatic mutation. Science Advances. 8(32). eabp8155–eabp8155. 10 indexed citations

Gruell, Henning, Kanika Vanshylla, Pinkus Tober‐Lau, et al.. (2022). mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nature Medicine. 28(3). 477–480. 243 indexed citations breakdown →

Korenkov, Michael, Martin Hellmich, Henning Gruell, et al.. (2022). Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals. Journal of Clinical Virology. 148. 105119–105119. 12 indexed citations

10.

Ercanoglu, Meryem S., Lutz Gieselmann, Manuel Koch, et al.. (2022). No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. iScience. 25(3). 103951–103951. 6 indexed citations

11.

Gruell, Henning, Kanika Vanshylla, Timm Weber, et al.. (2022). Antibody-mediated neutralization of SARS-CoV-2. Immunity. 55(6). 925–944. 76 indexed citations

12.

Gruell, Henning, Felix Dewald, Florian Klein, et al.. (2021). The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany. Viruses. 13(8). 1600–1600. 17 indexed citations

13.

Wunsch, Marie, Eva Heger, Martin Hufbauer, et al.. (2021). Safe and effective pool testing for SARS-CoV-2 detection. Journal of Clinical Virology. 145. 105018–105018. 9 indexed citations

14.

Niessl, Julia, Amy E. Baxter, Pilar Mendoza, et al.. (2020). Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity. Nature Medicine. 26(2). 222–227. 99 indexed citations

15.

Vanshylla, Kanika, Henning Gruell, Bárbara Müller, et al.. (2020). Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?. Vaccines. 8(4). 758–758. 11 indexed citations

16.

Vanshylla, Kanika, et al.. (2020). Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody. arXiv (Cornell University). 13 indexed citations

17.

Schoofs, Till, Christopher O. Barnes, Jovana Golijanin, et al.. (2019). Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. Immunity. 50(6). 1513–1529.e9. 57 indexed citations

18.

Gruell, Henning, Armin Tuchscherer, Thorsten Löffler, et al.. (2017). On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission. Clinical Infectious Diseases. 65(8). 1404–1406. 6 indexed citations

19.

Gruell, Henning & Florian Klein. (2014). Opening Fronts in HIV Vaccine Development: Tracking the development of broadly neutralizing antibodies. Nature Medicine. 20(5). 478–479. 8 indexed citations

20.

Gruell, Henning, Stylianos Bournazos, Jeffrey V. Ravetch, et al.. (2013). Antibody and Antiretroviral Preexposure Prophylaxis Prevent Cervicovaginal HIV-1 Infection in a Transgenic Mouse Model. Journal of Virology. 87(15). 8535–8544. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact